Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Abstract Introduction Tralokinumab and dupilumab are biological agents licensed for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients who are candidates for systemic treatment. However, no head-to-head studies of their efficacy have been conducted. This study indirectly co...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Tiago Torres, Anne Sohrt Petersen, Ulla Ivens, Albert Bosch Vilaro, John Stinson, José Manuel Carrascosa
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Adis, Springer Healthcare 2024-04-01
Schriftenreihe:	Dermatology and Therapy
Schlagworte:	Atopic dermatitis Dupilumab Matching-adjusted indirect comparison Topical corticosteroids Tralokinumab
Online-Zugang:	https://doi.org/10.1007/s13555-024-01143-x
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!